Healthcare M&A » By The Online Investor Staff, updated Sat., Jan. 23, 5:57 AM
Recent mergers and acquisitions in the Healthcare M&A category.
| This Slide: #84 of 100 |
Slide #84. Cumberland Pharmaceuticals — Vaprisol from Astellas Pharma US, Inc.
Acquirer:
Cumberland Pharmaceuticals (NASDAQ:CPIX)
Acquiree:
Vaprisol from Astellas Pharma US, Inc.
Details:
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol from Astellas Pharma US, Inc.
Cumberland Pharmaceuticals is a pharmaceutical company focused on the acquisition, development and commercialization of prescription products. Co.'s portfolio of U.S. Food and Drug Administration approved brands include: Acetadote® (acetylcysteine) Injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) Injection, for the treatment of pain and fever; Kristalose® (lactulose) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation; and Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease.
Open the CPIX Page at The Online Investor »
|
|||||||||||||||||||||
Open the CPIX Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 95th percentile
(ranked higher than approx. 95% of all stocks covered)
Analysts' Target Price: CPIX Stock Forecast Based on Zacks ABR data; powered by Xignite |
